Head to Head Stocks: Array BioPharma Inc. (NASDAQ:ARRY), Oceaneering International, Inc. (NYSE:OII)

earnings estimates

Array BioPharma Inc. (NASDAQ:ARRY)

Array BioPharma Inc. (NASDAQ:ARRY) closed at $41.97 on the last trading session with an increase of 4.79%, whereas, it previously closed at $40.05. The company has a market capitalization of $5.21 Billion. The company traded shares of 1.85 Million on the trading day while its three month average volume stands at 3.95 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Array BioPharma Inc. (NASDAQ:ARRY) produced diluted EPS of 0.8. The EPS estimate for next year as estimated by analysts is at 0.89 while EPS for next quarter is estimated at 0.05. Earnings per Share growth for this year is reported at 165.4, while the analysts estimated the EPS growth for next year at 0.89% and Earnings growth for next 5 years stands at 19.83% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 0%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Array BioPharma Inc. (NASDAQ:ARRY) is at 52.66 while the forward p/e is at 46.95. The P/S or Price to Sales ratio of Array BioPharma Inc. (NASDAQ:ARRY) stands at 5.69 and Price to Book or P/B for the most recent quarter stands at 13.35. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Array BioPharma Inc. (NASDAQ:ARRY) are reported at 1.1 and 1.9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Array BioPharma Inc. (NASDAQ:ARRY) stands at 0, 0 and 14.5 respectively

The trailing twelve month Revenue of Array BioPharma Inc. (NASDAQ:ARRY) is reported at 916.81 Million with income of 0. The outstanding shares of Array BioPharma Inc. (NASDAQ:ARRY) are 124.22 Million. The institutional Ownership of the shares of 69.06 stands at 0.80%, this figure is increased 0 in the last six months. The insider ownership for the shares of Array BioPharma Inc. (NASDAQ:ARRY) is ticked at 0.4%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Array BioPharma Inc. (NASDAQ:ARRY) is the Mean Target Price estimated by the analysts which stands at 43.81. The 52 week high of Array BioPharma Inc. (NASDAQ:ARRY) is placed at 48.88 and 52 week low is standing at 29.05.

Performance wise the shares of Array BioPharma Inc. (NASDAQ:ARRY) rose up 7.18% for the week, it also rise 9.01% for the monthly performance, while for the quarter it went down 0%. The shares increase 0% for the half year and flew up for the Year-To-Date performance. The shares of Array BioPharma Inc. (NASDAQ:ARRY) grew 0% for the yearly performance.

Oceaneering International, Inc. (NYSE:OII)

Oceaneering International, Inc. (NYSE:OII) closed at $6.33 on the last trading session with an increase of 1.61%, whereas, it previously closed at $6.23. The company has a market capitalization of $598.06 Million. The company traded shares of 1.47 Million on the trading day while its three month average volume stands at 1.28 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Oceaneering International, Inc. (NYSE:OII) produced diluted EPS of -7.91. The EPS estimate for next year as estimated by analysts is at -0.62 while EPS for next quarter is estimated at -0.23. Earnings per Share growth for this year is reported at -74.6, while the analysts estimated the EPS growth for next year at -0.62% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -23.7%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Oceaneering International, Inc. (NYSE:OII) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Oceaneering International, Inc. (NYSE:OII) stands at 0.3 and Price to Book or P/B for the most recent quarter stands at 1.14. The Price to Free Cash Flow ratio or P/FCF is reported at 45.65. The quick ratio and the current ratio of Oceaneering International, Inc. (NYSE:OII) are reported at 2.3 and 2.6 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Oceaneering International, Inc. (NYSE:OII) stands at -32.4, -102.3 and -17 respectively

The trailing twelve month Revenue of Oceaneering International, Inc. (NYSE:OII) is reported at 1.96 Billion with income of -783000000. The outstanding shares of Oceaneering International, Inc. (NYSE:OII) are 99.3 Million. The institutional Ownership of the shares of 88.7 stands at 0.80%, this figure is increased 0.49 in the last six months. The insider ownership for the shares of Oceaneering International, Inc. (NYSE:OII) is ticked at 0.2%, the figure is plummeted -1% in the last six months.

Some other important financial aspects to be discussed here for Oceaneering International, Inc. (NYSE:OII) is the Mean Target Price estimated by the analysts which stands at 6.85. The 52 week high of Oceaneering International, Inc. (NYSE:OII) is placed at 15.99 and 52 week low is standing at 2.01.

Performance wise the shares of Oceaneering International, Inc. (NYSE:OII) rose up 17.44% for the week, it also rise 59.85% for the monthly performance, while for the quarter it went down 18.54%. The shares increase 16.79% for the half year and plummeted for the Year-To-Date performance. The shares of Oceaneering International, Inc. (NYSE:OII) shrinked -52.55% for the yearly performance.